$72.6 Million is the total value of Virtus ETF Advisers LLC's 153 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ETP | New | ENERGY TRANSFER PRTNRS L Punit ltd partn | $4,122,000 | – | 127,467 | +100.0% | 5.68% | – |
| SXL | New | SUNOCO LOGISTICS PRTNRS L P | $3,325,000 | – | 132,642 | +100.0% | 4.58% | – |
| MPLX | New | MPLX LP | $2,874,000 | – | 96,788 | +100.0% | 3.96% | – |
| WPZ | New | WILLIAMS PARTNERS L P NEW | $2,870,000 | – | 140,345 | +100.0% | 3.95% | – |
| EQM | New | EQT MIDSTREAM PARTNERS LPunit ltd partn | $1,596,000 | – | 21,445 | +100.0% | 2.20% | – |
| EEP | New | ENBRIDGE ENERGY PARTNERS L P | $1,559,000 | – | 85,110 | +100.0% | 2.15% | – |
| TLLP | New | TESORO LOGISTICS LP | $1,202,000 | – | 26,334 | +100.0% | 1.66% | – |
| TRGP | New | TARGA RES CORP | $1,199,000 | – | 40,156 | +100.0% | 1.65% | – |
| OKS | New | ONEOK PARTNERS LPunit ltd partn | $973,000 | – | 30,989 | +100.0% | 1.34% | – |
| ET | New | ENERGY TRANSFER EQUITY L P | $888,000 | – | 124,532 | +100.0% | 1.22% | – |
| DCP | New | DCP MIDSTREAM PARTNERS LP | $778,000 | – | 28,568 | +100.0% | 1.07% | – |
| TBPH | New | THERAVANCE BIOPHARMA INC | $709,000 | – | 37,703 | +100.0% | 0.98% | – |
| MDVN | New | MEDIVATION INC | $653,000 | – | 14,197 | +100.0% | 0.90% | – |
| ENLK | New | ENLINK MIDSTREAM PARTNERS LP | $643,000 | – | 53,248 | +100.0% | 0.89% | – |
| LGND | New | LIGAND PHARMACEUTICALS INC | $594,000 | – | 5,543 | +100.0% | 0.82% | – |
| ARIA | New | ARIAD PHARMACEUTICALS INC | $592,000 | – | 92,602 | +100.0% | 0.82% | – |
| IRWD | New | IRONWOOD PHARMACEUTICALS INC | $588,000 | – | 53,788 | +100.0% | 0.81% | – |
| RPTP | New | RAPTOR PHARMACEUTICAL CORP | $584,000 | – | 126,869 | +100.0% | 0.80% | – |
| ENTA | New | ENANTA PHARMACEUTICALS INC | $549,000 | – | 18,689 | +100.0% | 0.76% | – |
| WGP | New | WESTERN GAS EQUITY PARTNERS | $546,000 | – | 15,311 | +100.0% | 0.75% | – |
| BIIB | New | BIOGEN INC | $532,000 | – | 2,045 | +100.0% | 0.73% | – |
| PDLI | New | PDL BIOPHARMA INC | $528,000 | – | 158,634 | +100.0% | 0.73% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $487,000 | – | 5,902 | +100.0% | 0.67% | – |
| XNPT | New | XENOPORT INC | $458,000 | – | 101,554 | +100.0% | 0.63% | – |
| EXEL | New | EXELIXIS INC | $458,000 | – | 114,429 | +100.0% | 0.63% | – |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $409,000 | – | 3,669 | +100.0% | 0.56% | – |
| ACOR | New | ACORDA THERAPEUTICS INC | $408,000 | – | 15,412 | +100.0% | 0.56% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $400,000 | – | 5,033 | +100.0% | 0.55% | – |
| TCP | New | TC PIPELINES LP | $389,000 | – | 8,068 | +100.0% | 0.54% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $381,000 | – | 1,057 | +100.0% | 0.52% | – |
| INCY | New | INCYTE CORP | $371,000 | – | 5,113 | +100.0% | 0.51% | – |
| INO | New | INOVIO PHARMACEUTICALS INC | $353,000 | – | 40,487 | +100.0% | 0.49% | – |
| HALO | New | HALOZYME THERAPEUTICS INC | $348,000 | – | 36,695 | +100.0% | 0.48% | – |
| MNTA | New | MOMENTA PHARMACEUTICALS INC | $344,000 | – | 37,282 | +100.0% | 0.47% | – |
| NGL | New | NGL ENERGY PARTNERS LP | $303,000 | – | 40,261 | +100.0% | 0.42% | – |
| AGEN | New | AGENUS INC | $268,000 | – | 64,543 | +100.0% | 0.37% | – |
| FPRX | New | FIVE PRIME THERAPEUTICS INC | $257,000 | – | 6,321 | +100.0% | 0.35% | – |
| XNCR | New | XENCOR INC | $242,000 | – | 18,040 | +100.0% | 0.33% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $232,000 | – | 27,420 | +100.0% | 0.32% | – |
| ADAP | New | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $229,000 | – | 28,182 | +100.0% | 0.32% | – |
| ABUS | New | ARBUTUS BIOPHARMA CORP | $225,000 | – | 54,471 | +100.0% | 0.31% | – |
| ZIOP | New | ZIOPHARM ONCOLOGY INC | $215,000 | – | 29,020 | +100.0% | 0.30% | – |
| RGLS | New | REGULUS THERAPEUTICS INC | $212,000 | – | 30,524 | +100.0% | 0.29% | – |
| JUNO | New | JUNO THERAPEUTICS INC | $204,000 | – | 5,353 | +100.0% | 0.28% | – |
| TGTX | New | TG THERAPEUTICS INC | $204,000 | – | 23,986 | +100.0% | 0.28% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $201,000 | – | 4,954 | +100.0% | 0.28% | – |
| EPZM | New | EPIZYME INC | $199,000 | – | 16,400 | +100.0% | 0.27% | – |
| ACHN | New | ACHILLION PHARMACEUTICALS IN | $198,000 | – | 25,711 | +100.0% | 0.27% | – |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $197,000 | – | 1,535 | +100.0% | 0.27% | – |
| ARRY | New | ARRAY BIOPHARMA INC | $196,000 | – | 66,376 | +100.0% | 0.27% | – |
| SRNE | New | SORRENTO THERAPEUTICS INC | $194,000 | – | 36,130 | +100.0% | 0.27% | – |
| ENLC | New | ENLINK MIDSTREAM LLC | $194,000 | – | 17,251 | +100.0% | 0.27% | – |
| USO | New | UNITED STATES OIL FUND LPunits | $194,000 | – | 20,000 | +100.0% | 0.27% | – |
| AKBA | New | AKEBIA THERAPEUTICS INC | $193,000 | – | 21,430 | +100.0% | 0.27% | – |
| BPMC | New | BLUEPRINT MEDICINES CORP | $189,000 | – | 10,484 | +100.0% | 0.26% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $188,000 | – | 4,760 | +100.0% | 0.26% | – |
| ESPR | New | ESPERION THERAPEUTICS INC NE | $186,000 | – | 11,011 | +100.0% | 0.26% | – |
| AIMT | New | AIMMUNE THERAPEUTICS INC | $185,000 | – | 13,666 | +100.0% | 0.26% | – |
| KITE | New | KITE PHARMA INC | $181,000 | – | 3,940 | +100.0% | 0.25% | – |
| BLUE | New | BLUEBIRD BIO INC | $181,000 | – | 4,252 | +100.0% | 0.25% | – |
| INFI | New | INFINITY PHARMACEUTICALS INC | $179,000 | – | 34,021 | +100.0% | 0.25% | – |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $176,000 | – | 2,799 | +100.0% | 0.24% | – |
| VSAR | New | VERSARTIS INC | $176,000 | – | 21,910 | +100.0% | 0.24% | – |
| FGEN | New | FIBROGEN INC | $175,000 | – | 8,215 | +100.0% | 0.24% | – |
| MCRB | New | SERES THERAPEUTICS INC | $175,000 | – | 6,580 | +100.0% | 0.24% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $168,000 | – | 7,828 | +100.0% | 0.23% | – |
| QURE | New | UNIQURE NV | $168,000 | – | 14,182 | +100.0% | 0.23% | – |
| IMGN | New | IMMUNOGEN INC | $164,000 | – | 19,257 | +100.0% | 0.23% | – |
| LBIO | New | LION BIOTECHNOLOGIES INC | $164,000 | – | 32,352 | +100.0% | 0.23% | – |
| KPTI | New | KARYOPHARM THERAPEUTICS INC | $160,000 | – | 17,923 | +100.0% | 0.22% | – |
| CYTK | New | CYTOKINETICS INC | $156,000 | – | 22,124 | +100.0% | 0.22% | – |
| ONCE | New | SPARK THERAPEUTICS INC | $155,000 | – | 5,251 | +100.0% | 0.21% | – |
| RARE | New | ULTRAGENYX PHARMACEUTICAL IN | $152,000 | – | 2,404 | +100.0% | 0.21% | – |
| XLRN | New | ACCELERON PHARMA INC | $152,000 | – | 5,756 | +100.0% | 0.21% | – |
| PRTA | New | PROTHENA CORP PLC | $150,000 | – | 3,650 | +100.0% | 0.21% | – |
| SAGE | New | SAGE THERAPEUTICS INC | $148,000 | – | 4,602 | +100.0% | 0.20% | – |
| IDRA | New | IDERA PHARMACEUTICALS INC | $147,000 | – | 74,038 | +100.0% | 0.20% | – |
| AXGT | New | AXOVANT SCIENCES LTD | $144,000 | – | 12,579 | +100.0% | 0.20% | – |
| CEMP | New | CEMPRA INC | $141,000 | – | 8,058 | +100.0% | 0.19% | – |
| OMED | New | ONCOMED PHARMACEUTICALS INC | $125,000 | – | 12,369 | +100.0% | 0.17% | – |
| TTPH | New | TETRAPHASE PHARMACEUTICALS I | $123,000 | – | 26,478 | +100.0% | 0.17% | – |
| DNAI | New | PRONAI THERAPEUTICS INC | $121,000 | – | 17,902 | +100.0% | 0.17% | – |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $120,000 | – | 7,582 | +100.0% | 0.16% | – |
| NK | New | NANTKWEST INC | $120,000 | – | 14,563 | +100.0% | 0.16% | – |
| VTAE | New | VITAE PHARMACEUTICALS INC | $116,000 | – | 17,530 | +100.0% | 0.16% | – |
| NWBO | New | NORTHWEST BIOTHERAPEUTICS IN | $115,000 | – | 78,696 | +100.0% | 0.16% | – |
| ADRO | New | ADURO BIOTECH INC | $102,000 | – | 7,966 | +100.0% | 0.14% | – |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $98,000 | – | 3,321 | +100.0% | 0.14% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS | $74,000 | – | 26,246 | +100.0% | 0.10% | – |
| SEP | New | SPECTRA ENERGY PARTNERS LP | $70,000 | – | 1,449 | +100.0% | 0.10% | – |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $65,000 | – | 17,247 | +100.0% | 0.09% | – |
| NS | New | NUSTAR ENERGY LP | $64,000 | – | 1,588 | +100.0% | 0.09% | – |
| PTCT | New | PTC THERAPEUTICS INC | $57,000 | – | 8,777 | +100.0% | 0.08% | – |
| CMRX | New | CHIMERIX INC | $37,000 | – | 7,232 | +100.0% | 0.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
| REGENERON PHARMACEUTICALS | 31 | Q3 2023 | 1.8% |
| INCYTE CORP | 31 | Q3 2023 | 2.1% |
| ENANTA PHARMACEUTICALS INC | 31 | Q3 2023 | 2.2% |
| EXELIXIS INC | 31 | Q3 2023 | 1.8% |
| VANDA PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
| IRONWOOD PHARMACEUTICALS INC | 31 | Q3 2023 | 2.0% |
| LIGAND PHARMACEUTICALS INC | 31 | Q3 2023 | 1.5% |
| GILEAD SCIENCES INC | 31 | Q3 2023 | 1.6% |
| HALOZYME THERAPEUTICS INC | 31 | Q3 2023 | 1.7% |
View Virtus ETF Advisers LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-15 |
| 13F-HR | 2023-11-07 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Virtus ETF Advisers LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.